11/1/2013
Apologies for the delay in the making of
this blog; this is a first for me so I’m fumbling with the wheels but I’m eager
and interested to know where my accumulated reflections upon my first industry
experience will take me and what you think of them. I’ll be posting up the journal recounts that I have recorded relating to my experience thus far so
please feel free to read and join in with comments, queries or whatever tickles
your curiosity.
I thought I would start off by laying the
foundation and giving a brief insight into what exactly Johnson & Johnson,
more famously known for their baby products, can do and their breadth of
capabilities. Products made by Johnson & Johnson are frequently perceived
to be limited to those which are often seen on ads, catalogues and on the shelves
of your local woollies supermarket, known as fast-moving-consumer-goods (FMCGs)
but this is quite deceptive and misleading as they produce just as many medical
and pharmaceutical products as consumer goods, if not more.
A sneak peak into my IT1 Pre-Placement
Sponsor Organisation Analysis will give a better idea of the industry J&J
is a part of:
1. Nature
of industry and its economic significance
Johnson & Johnson
(J&J) is one of the world’s most comprehensive and broadly based health
care companies, operating not only in the consumer health care industry but
also the medical equipment and pharmaceutical industry. They provide a range of
different products and essentials to hospitals, doctors, patients and the
everyday consumer. Products sold to doctors and hospitals pertain to the array
of procedures and methods that address the medical needs of people, thereby
indirectly affecting the wellbeing of many around the world.
2. Main
participants in the industry, market concentration, products
Major competitors
in the medical equipment and supplies manufacturing industry include companies
like Baxter International, Boston Scientific and Medtronic. Other competitors are Pfizer,
Novartis, AstraZeneca and MSD. As demand
is driven by population demographics and advances in medical knowledge and
technology, profitability is dependent on the ability to produce superior
goods. Large organizations like J&J are able to achieve economies of scale
in manufacturing and R&D while small companies can specialize in a particular
market sector.
3. Accounting issues relevant
to the industry
There are two main
accounting issues relevant to this industry. As J&J is listed on the New
York Stock Exchange (NYSE), all affiliates of J&J are required to report
against US GAAP. However as different accounting standards have been adopted in
different countries there have been many difficulties and issues arising from
the reconciliation of the domestic country’s reporting requirements and US
GAAP. Initiatives to address this has been to conduct certified internal audits
(CIA) by the US once every three years to regulate compliance and consistency
of accounting methods across the world.
A second accounting
issue relates to the rebates and subsidies received from the government and the
method of disclosing this information along with returns and allowances. There
have been many complexities and issues with applying rebates to products as
their discount varies from product to product. Returns and allowances give rise
to classification issues on the BS and PL. One of the reasons for this is
because if a surgeon orders medical equipment of a particular size, J&J
must deliver not only the requested size but 2-3 sizes above and below that as
well to guard against any miscalculations that may only be realized during
surgery. The equipment that is unused is returned but the amount is unknown
until received.
4. Key challenges, issues
and developments facing the industry and the accounting profession
One of the
developments being encouraged at J&J is a well-balanced life style through
the implementation of a decentralized management system and the honouring of a
credo which atypically acknowledges that our first responsibility is to our
customers and then our shareholders.
A key challenge facing
the industry relates to the demographical nature of Australia. A trend of this
industry is that it has been consistently growing due to the increase in the
aging population across the world. There are more people getting old then there
are being born and this means that the number young people who are qualified to
care for the elderly are becoming increasingly scarce with continually new
illnesses to combat.